# A Clinical Study to Evaluate the Safety of MF1, a New Treatment for Parkinson's Disease-related Disorders (MF1 Study)

> **NCT07666022** · PHASE1 · RECRUITING · sponsor: **University of Shizuoka** · enrollment: 58 (estimated)

## Conditions studied

- Healthy Adult Male
- PARKINSON DISEASE (Disorder)

## Interventions

- **DRUG:** MF-1
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07666022
- **Lead sponsor:** University of Shizuoka
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2028-09-30
- **Final completion:** 2028-10-31
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2026-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07666022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07666022, "A Clinical Study to Evaluate the Safety of MF1, a New Treatment for Parkinson's Disease-related Disorders (MF1 Study)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07666022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*